pirfenidone has been researched along with Esophageal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, R; Chen, C; Kang, M; Li, Z; Liao, S; Xu, B; Xue, D; Yang, Y; Zeng, B | 1 |
1 trial(s) available for pirfenidone and Esophageal Neoplasms
| Article | Year |
|---|---|
Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial.
Topics: Clinical Trials, Phase II as Topic; Cytokines; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Lung Injury; Radiation Injuries; Randomized Controlled Trials as Topic | 2022 |